Citation Impact
Citing Papers
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Carbamazepine‐hypersensitivity: assessment of clinical and in vitro chemical cross‐reactivity with phenytoin and oxcarbazepine.
1991
The FGF family: biology, pathophysiology and therapy
2009 Standout
Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir
2002 Standout
Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide
1995
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
Sperm banking and assisted reproduction treatment for couples following cancer treatment of the male partner
2001
Tumor necrosis factor-α, and interleukin-1β production by human fetal Kupffer cells
1991 StandoutNobel
Adverse drug reactions: definitions, diagnosis, and management
2000 Standout
Maternal Periconceptional Alcohol Consumption and Risk of Orofacial Clefts
2007
Cachectin/tumor necrosis factor-alpha formation in human decidua. Potential role of cytokines in infection-induced preterm labor.
1989 StandoutNobel
Indomethacin in the Treatment of Premature Labor
1988
Stress and Immune Responses After Surgical Treatment for Regional Breast Cancer
1998
Mitochondrial Dysfunction in C. elegans Activates Mitochondrial Relocalization and Nuclear Hormone Receptor-Dependent Detoxification Genes
2019 StandoutNobel
Retinopathy of prematurity
2013 Standout
Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
1998
Drug-Induced Hepatotoxicity
2003 Standout
Testicular sperm extraction (TESE) and ICSI in patients with permanent azoospermia after chemotherapy
2003
Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation of genotype-environment interactions from a population-based case-control study of orofacial clefts
1999
Computer‐Assisted Evaluation of Adverse Events Using a Bayesian Approach
1994
In-Vitro Assessment of a Hypersensitivity Syndrome Associated with Sorbinil
1991
Cleft lip and palate: understanding genetic and environmental influences
2011 Standout
Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease
1996 Standout
Assay of bacterial endotoxin (lipopolysaccharide) in human amniotic fluid: Potential usefulness in diagnosis and management of preterm labor
1988
Familial occurrence of hypersensitivity to phenytoin
1991
Cleft lip and palate
2009 Standout
An evaluation of chromatin condensation and DNA integrity in the spermatozoa of men with cancer before and after therapy
2005
Why degradable polymers undergo surface erosion or bulk erosion
2002 Standout
Biodegradable polymeric nanoparticles as drug delivery devices
2001 Standout
Clinical Applications of Research on Angiogenesis
1995 Standout
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.
1992 StandoutNobel
Drug repositioning: identifying and developing new uses for existing drugs
2004 Standout
Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally
1995
Folate intake, markers of folate status and oral clefts: is the evidence converging?
2008
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Isolation of germ cells from human testicular tissue for low temperature storage and autotransplantation
2001
Mechanisms of halothane toxicity: Novel insights
1993
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
2000 Standout
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Allergic Rash Due to Antiepileptic Drugs: Clinical Features and Management
1991
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
1988
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Effects of Thalidomide and Related Metabolites in a Mouse Corneal Model of Neovascularization
1997
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
1999
Autoantibodies to Folate Receptor α During Early Pregnancy and Risk of Oral Clefts in Denmark
2010
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
2001 Standout
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers
1994
A marker for Stevens–Johnson syndrome
2004 StandoutNature
Follow-up of sperm concentration and motility in patients with lymphoma
2000
Analysis of theEPHX1 113 polymorphism andGSTM1 homozygous null polymorphism and oral clefting associated with maternal smoking
2001
The mechanism of the suicidal reductive inactivation of microsomal cytochrome P-450 by halothane
1991
Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens
2004
Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review
1983
The range of PaO2 variation determines the severity of oxygen-induced retinopathy in newborn rats.
1995
Differences in Metabolism of Sulfonamides Predisposing to Idiosyncratic Toxicity
1986
Serum Beta-Carotene, Vitamins a and E, Selenium, and the Risk of Lung Cancer
1986
Fluorine in medicinal chemistry
2007 Standout
Polylactic Acid Technology
2000 Standout
Prostanoid Receptors: Structures, Properties, and Functions
1999 Standout
Polymeric Systems for Controlled Drug Release
1999 Standout
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation
1983 StandoutScienceNobel
Preterm labor: Its diagnosis and management
1986
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
The mechanism of halothane binding to microsomal cytochrome P450
1974
Fluorinated Organics in the Biosphere
1997
Controlled Release of a Luteinizing Hormone-Releasing Hormone Analogue from Poly(d,l-lactide—co-glycolide) Microspheres
1984
Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants.
1996
Animal models of oxygen-induced retinopathy
2003
Knowledge and Experience Regarding Cancer, Infertility, and Sperm Banking in Younger Male Survivors
2002
Infant TGF-Alpha Genotype, Orofacial Clefts, and Maternal Periconceptional Multivitamin Use
1998
Compound-Specific, Quantitative Characterization of Organic Fluorochemicals in Biological Matrices
2001 Standout
Development of Biodegradable and Injectable Latices for Controlled Release of Potent Drugs
1981
Thalidomide is an inhibitor of angiogenesis.
1994 Standout
TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients
2001
Sustained Drug Delivery Systems II: Factors Affecting Release Rates from Poly(ε-caprolactone) and Related Biodegradable Polyesters
1979
Identification of Mechanism-Based Inactivation in P450-Catalyzed Cyclopropanation Facilitates Engineering of Improved Enzymes
2016 StandoutNobel
Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study
1983 Standout
Mechanisms of Diabetic Complications
2013 Standout
Initiation of human parturition. XII. Biosynthesis and metabolism of prostaglandins in human fetal membranes and uterine decidua.
1981
Apparently normal phenytoin metabolism in a patient with phenytoin‐ induced rash and lymphadenopathy.
1987
Human Placental Transfer of the Prostaglandin Inhibitor Sulindac Using an In Vitro Model
1995
Polylactide. II. Viscosity–molecular weight relationships and unperturbed chain dimensions
1979
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
2004
Epoxidation of olefins by cytochrome P450: Evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant
1998
Multiple activated oxygen species in P450 catalysis: contributions To specificity in drug metabolism.
1998
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2
2001 StandoutNobel
Serum levels of free fatty acids in the first trimester of pregnancy: Effect of acetylsalicylic acid
1982
Mechanism of Oxidation Reactions Catalyzed by Cytochrome P450 Enzymes
2004 Standout
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications
2002 Standout
Cutaneous Drug Reactions
2001
Sustained drug delivery systems. I. The permeability of poly(ϵ‐caprolactone), poly(DL ‐lactic acid), and their copolymers
1979
Oxytocin and the initiation of human parturition
1981
Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice
2002 StandoutNobel
Cytochrome P450 and Chemical Toxicology
2007
Oncologists’ Attitudes and Practices Regarding Banking Sperm Before Cancer Treatment
2002
Structure and Chemistry of Cytochrome P450
2005 Standout
Works of David A. Blake being referenced
Anticonvulsant toxicity in vitro: possible role of arene oxides.
1981
DISPOSITION OF THALIDOMIDE IN RABBITS AND RATS
1968
Do men undergoing sterilizing cancer treatments have a fertile future?
1998
Phenytoin teratogenesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue.
1977
Pharmacokinetic studies on quinacrine following intrauterine administration to cynomolgus monkeys
1982
Predisposition to Phenytoin Hepatotoxicity Assessed in Vitro
1981
Lack of maternal metabolic, endocrine, and environmental influences in the etiology of cleft lip with or without cleft palate.
1985
Anesthesia LXXIV: Biotransformation of fluroxene—I. Metabolism in mice and dogs in vivo
1967
Differences in the Biotransformation of Halothane in Man
1970
Long-acting delivery systems for narcotic antagonists. 1
1973
Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
1981
The influence of aspirin on the course of induced midtrimester abortion
1976
Folate, carotene, and smoking
1982
Animal toxicity of 2,2,2-trifluoroethanol
1969
1302 RETROLENTAL FIBROPLASIA: EVIDENCE FOR A ROLE OF THE PROSTAGLANDIN CASCADE IN THE PATHOGENESIS OF OXYGENINDUCED RETINOPATHY IN THE NEWBORN BEAGLE
1981
The inhibition of premature labor with indomethacin
1980
Absence of mutagenic activity of trifluoroethanol and its metabolites in Salmonella typhimurium
1981
Retrolental Fibroplasia: Evidence for a Role of the Prostaglandin Cascade in the Pathogenesis of Oxygen-Induced Retinopathy in the Newborn Beagle
1981
A COMPARISON OF THE TERATOGENIC ACTIVITY OF THALIDOMIDE IN RABBITS AND RATS
1968
13, 14-Dihydro-15-keto-prostaglandin F2 concentrations in human plasma and amniotic fluid
1979
Halothane Biotransformation in Man
1971